Trial Profile
Efficacy and tolerability of rizatriptan in patients aged 6-17 with migraine
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Aug 2012
Price :
$35
*
At a glance
- Drugs Rizatriptan (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 28 Apr 2012 Results presented at the 64th Annual Meeting of the American Academy of Neurology.
- 25 Jul 2011 New trial record
- 05 Jun 2011 Results presented at the 53rd Annual Scientific Meeting of the American Headache Society.